Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03946800
Title A Study of MEDI1191 Alone and in Combination With Durvalumab in Subjects With Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors MedImmune LLC
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ESP

Facility Status City State Zip Country Details
Research Site La Jolla California 92093 United States Details
Research Site Los Angeles California 90025 United States Details
Research Site Los Angeles California 90089 United States Details
Research Site Bronx New York 10461 United States Details
Research Site New York New York 10029 United States Details
Research Site New York New York 10065 United States Details
Research Site Providence Rhode Island 02903 United States Details
Research Site Houston Texas 77030 United States Details
Research Site Barcelona 08035 Spain Details
Research Site Madrid 28027 Spain Details
Research Site Pamplona 31008 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field